Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: Prediction of ovarian response and cumulative treatment outcome in good-prognosis patients

Fertility and Sterility

Volumn 99, Issue 6, 2013, Pages

  Arce, Joan Carles ^a   La Marca, Antonio ^b   Mirner Klein, Bjarke ^a   Nyboe Andersen, Anders ^c   Fleming, Richard ^d  

^a Ferring Pharmaceuticals AS   (Denmark)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Antim llerian hormone; GnRH antagonist; live birth; ovarian response; pregnancy

Indexed keywords

GANIRELIX; INHIBIN B; MUELLERIAN INHIBITING FACTOR; RECOMBINANT FOLLITROPIN;

ADULT; ANTRAL FOLLICLE COUNT; ARTICLE; BLASTOCYST; CONTROLLED STUDY; CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; HEALTH CARE FACILITY; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE INFERTILITY; MENOPAUSE; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84876951808     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.12.048     Document Type: Article

References (29)

1. S.L. Broer, B. Mol, M. Dólleman, B.C. Fauser, and F.J. Broekmans The role of anti-müllerian hormone assessment in assisted reproductive technology outcome Curr Opin Obstet Gynecol 22 2010 193 201
2. A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, and A.C. Artenisio Anti-müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) Hum Reprod Update 16 2010 113 130
3. E. Anckaert, J. Smitz, J. Schiettecatte, B. Klein, and J.-C. Arce The value of anti-müllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response, dose adjustments, embryo quality and pregnancy Hum Reprod 27 2012 1829 1839
4. A. Hazout, P. Bouchard, D.B. Seifer, P. Aussage, A.M. Junca, and P. Cohen-Bacrie Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol Fertil Steril 82 2004 1323 1329
5. S. Muttukrishna, H. Suharjono, H. McGarrigle, and M. Sathanandan Inhibin B and anti-müllerian hormone: markers of ovarian response in IVF/ICSI patients? BJOG 111 2004 1248 1253
6. L.G. Nardo, T.A. Gelbaya, H. Wilkinson, S.A. Roberts, A. Yates, and P. Pemberton Circulating basal anti-müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization Fertil Steril 92 2009 1586 1593
7. J. Peñarrubia, F. Fábregues, D. Manau, M. Creus, G. Casals, and R. Casamitjana Basal and stimulation day 5 anti-müllerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment Hum Reprod 20 2005 915 922
8. D.B. Seifer, D.T. MacLaughlin, B.P. Christian, B. Feng, and R.M. Shelden Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles Fertil Steril 77 2002 468 471
9. S.L. Broer, B.W. Mol, D. Hendriks, and F.J. Broekmans The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Fertil Steril 91 2009 705 714
10. S.L. Broer, M. Dólleman, B.C. Opmeer, B.C. Fauser, B.W. Mol, and F.J. Broekmans AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-Analysis Hum Reprod Update 17 2011 46 54
11. T.H. Lee, C.H. Liu, C.C. Huang, Y.L. Wu, Y.T. Shih, H.N. Ho, and Y.S. Yang Serum anti-müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles Hum Reprod 23 2008 160 167
12. S.M. Nelson, R.W. Yates, and R. Fleming Serum anti-müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles-implications for individualization of therapy Hum Reprod 22 2007 2414 2421
13. J.M. Smeenk, F.C. Sweep, G.A. Zielhuis, J.A. Kremer, C.M. Thomas, and D.D. Braat Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracytoplasmic sperm injection Fertil Steril 87 2007 223 226
14. J.R. Lee, S.H. Kim, S.M. Kim, B.C. Jee, S.Y. Ku, and C.S. Suh Anti-müllerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction Hum Reprod 25 2010 2597 2604
15. A. Nyboe Andersen, H. Witjes, K. Gordon, B. Mannaerts Xpect investigators Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment Hum Reprod 26 2011 3413 3423
16. N.P. Polyzos, D. Stoop, C. Blockeel, P. Adriaensen, P. Platteau, and E. Anckaert Anti-müllerian hormone for the assessment of ovarian response in GnRH-Antagonist-treated oocyte donors Reprod Biomed Online 24 2012 532 539
17. P. Devroey, A. Pellicer, A. Nyboe Andersen, J.-C. Arce, and Menopur in GnRH Antagonist Cycles with Single Embryo Transfer (MEGASET) Trial Group A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer Fertil Steril 97 2012 561 571
18. D.K. Gardner, and W.B. Schoolcraft In-vitro culture of human blastocysts R. Jansen, D. Mortimer, Towards reproductive certainty: fertility and genetics beyond 1999 1999 Parthenon New York 378 388
19. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing areas under two or more correlated receiver operating characteristics curves: a nonparametric approach Biometrics 44 1988 837 845
20. J. van Disseldorp, C.B. Lambalk, J. Kwee, C.W. Looman, M.J. Eijkemans, and B.C. Fauser Comparison of inter- and intra-cycle variability of anti-müllerian hormone and antral follicle counts Hum Reprod 25 2010 221 227
21. H. Binder, R. Strick, O. Zaherdoust, R. Dittrich, M. Hamori, and M.W. Beckmann Assessment of FSHR variants and antimüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation Fertil Steril 97 2012 1169 1175
22. F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol, and C.B. Lambalk A systematic review of tests predicting ovarian reserve and IVF outcome Hum Reprod Update 12 2006 685 718
23. E.R. Klinkert, F.J. Broekmans, C.W. Looman, J.D. Habbema, and E.R. te Velde Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial Hum Reprod 20 2005 611 615
24. D.N. Lekamge, M. Lane, R.B. Gilchrist, and K.P. Tremellen Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve J Assist Reprod Genet 25 2008 515 521
25. S.M. Nelson, R.W. Yates, H. Lyall, M. Jamieson, I. Traynor, and M. Gaudoin Anti-müllerian hormone-based approach to controlled ovarian stimulation for assisted conception Hum Reprod 24 2009 867 875
26. A.P. Yates, O. Rustamov, S.A. Roberts, H.Y. Lim, P.W. Pemberton, and A. Smith Anti-müllerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF Hum Reprod 26 2011 2353 2362
27. C. Fiçicioglu, T. Kutlu, E. Baglam, and Z. Bakacak Early follicular antimüllerian hormone as an indicator of ovarian reserve Fertil Steril 85 2006 592 596
28. I.A. van Rooij, F.J. Broekmans, E.R. te Velde, B.C. Fauser, L.F. Bancsi, and F.H. de Jong Serum anti-müllerian hormone levels: a novel measure of ovarian reserve Hum Reprod 17 2002 3065 3071
29. G.S. Nakhuda, N.C. Douglas, M.H. Thornton, M.M. Guarnaccia, R. Lobo, and M.V. Sauer Anti-müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors Reprod Biomed Online 20 2010 42 47